Casdin Capital, LLC 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-27 6:51 pm Purchase |
2024-11-20 | 13G | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 4,592,316 5.400% |
1,380,000 (+42.96%) |
Filing |
| 2024-11-14 4:08 pm Sale |
2024-09-30 | 13G | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 3,212,316 3.800% |
-1,978,190 (-38.11%) |
Filing |
| 2024-04-18 4:36 pm Purchase |
2024-04-11 | 13G | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 5,190,506 6.080% |
1,984,126 (+61.88%) |
Filing |
| 2024-04-08 9:03 pm Sale |
2024-02-29 | 13D | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 3,206,380 4.950% |
-16,560 (-0.51%) |
Filing |
| 2022-10-11 2:09 pm Sale |
2022-10-01 | 13D | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 3,222,940 5.500% |
-23,184 (-0.71%) |
Filing |
| 2021-07-29 2:11 pm Purchase |
2021-06-17 | 13D | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 3,246,124 5.900% |
3,246,124 (New Position) |
Filing |